Delivery Order HHSN272201300018I-HHSN27200012
Award Date 6/14/16
Potential Completion Date 6/14/22
Potential Value $2.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Atlanta, GA 30322, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for a task order under the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery/indefinite quantity (IDIQ) contract. The task order, valued at $1,896,784.68, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University as the prime contractor. The task order is for a clinical research study titled "PROTOCOL 15-0020: TARGETED REDUCTION OF ANTIBIOTICS USING PROCALCITONIN IN A MULTI-CENTER,...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Baylor College of Medicine, a private health sciences university in Houston, Texas. The contract has an award value of $850,632.27 and is for a clinical trial to evaluate the use of procalcitonin to guide the targeted reduction of antibiotics in the treatment of suspect lower respiratory tract infections in outpatient adults. This...
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Emory University, a private university and research institution located in Atlanta, Georgia. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which focuses on the development and evaluation of vaccines and treatments for infectious diseases. The contract has a total potential value of $263,956.53 and a period of performance ending on...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract is part of NIAID's Vaccine and Treatment Evaluation Units (VTEU) program, which supports the evaluation of vaccines and treatments for infectious diseases. The contract has a ceiling value of $3,128,475.78 and a period of performance through December...
- This is a delivery order issued under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, valued at $3,383,868.10, is for Emory University to provide protocol development, implementation, and assays for a prospective natural history study of U.S. patients with a history of Zika virus infection. The contract is not set...
- This is a federal contract award to Emory University, a private research institution in Atlanta, Georgia. The contract, valued at $10,564,646.55, is a delivery order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Contract with the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract supports Emory's research and services related to the VTEU program, which focuses on the...
- This is a federal contract award to Emory University, a private research institution in Atlanta, Georgia, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract, with a ceiling value of $5,025,057.70, is for the development, implementation, and research of laboratory assays for a Phase I clinical trial to examine the safety, immunogenicity, and 'omics response to MVA-multi filo and AD26 Zaire vaccines in healthy...
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Emory University, a private research institution, with a ceiling value of $1,050,622.47. The delivery order is under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Contract, which enables NIAID to fund research and development of medical countermeasures against infectious diseases, including those...
- <p>The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $879,633 cost no fee delivery order contract to Emory University Office Of Sponsored Programs Division for TASK ORDER B-4 covering the period from August 1, 2022 through March 20, 2027. The contract supports the National Interest Action Code of Coronavirus COVID-19. Performance will take place in Atlanta, Georgia.</p>
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Emory University, a private research institution in Atlanta, Georgia. The contract, valued at $6,963,671.38, is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports the development and evaluation of vaccines and treatments for infectious diseases. The contract has no set-aside designation. Emory University,...
- HHSN272201300018IIndefinite Delivery Contract
- HHSN272201300018I-HHSN27200012Delivery Order
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to Emory University. The contract is for a study entitled "PROTOCOL 15-0020 TARGETED REDUCTION OF ANTIBIOTICS USING PROCALCITONIN IN A MULTI-CENTER, RANDOMIZED, BLINDED, PLACEBO-CONTROLLED NON-INFERIORITY STUDY OF AZITHROMYCIN TREATMENT IN OUTPATIENT ADULTS WITH SUSPECT LOWER RESPIRATORY TRACT INFECTION (LRTI) AND A PROCALCITONIN LEVEL OF 0.1 NG/ML." This is a $2,459,475.85 cost-no-fee contract that is part of NIAID's Vaccine and Treatment Evaluation Units (VTEU) program. The contract has a period of performance through June 14, 2022 and does not have a set-aside designation.
Generated 4/1/25, 8:38 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
VACCINE AND TREATMENT EVALUATION UNITS (VTEU) | RFP-NIAID-DMID-NIHAI2012144 | Department of Health and Human Services National Institutes of Health | Award Notice 1/2 | 4/27/12, 1:53 PM | |
VACCINE AND TREATMENT EVALUATION UNITS (VTEU) | RFP-NIAID-DMID-NIHAI2012144 | Department of Health and Human Services National Institutes of Health | Award Notice 2/2 | 6/5/12, 2:56 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00012 | Close Out | ($710k) | 6/14/22 | |
| P00011 | Supplemental Agreement for work within scope | ($3) | 11/3/20 | |
| P00010 | Supplemental Agreement for work within scope | $0 | 3/17/20 | |
| P00009 | Exercise an Option | $455.6k | 12/13/19 | |
| P00008 | Supplemental Agreement for work within scope | $0 | 5/21/19 |